Javascript must be enabled to continue!
Rapid detection of Enterococcus and vancomycin resistance using recombinase polymerase amplification
View through CrossRef
Vancomycin-resistant enterococci (VRE), especially
Enterococcus faecium
, have been a global concern, often causing serious healthcare-associated infections. We established a rapid approach for detecting
E. faecium
and vancomycin-resistance genes (
vanA
and
vanB
) in clinical samples using isothermal recombinase polymerase amplification (RPA) combined with a lateral-flow (LF) strip. Specific RPA primer sets and probes for
ddl
(to identify the presence of
E. faecium
)
vanA
and
vanB
genes were designed. The RPA reaction was performed under isothermal condition at 37 °C within 20 min and read using the LF strip within a further 5 min. A total of 141 positive blood-cultures and 136 stool/rectal swab samples were tested using RPA-LF method compared to the conventional PCR method. The RPA-LF method exhibited 100% sensitivity in both blood-culture (60
E. faecium
; 35
vanA
type and two
vanB
type) and stool/rectal-swab samples (63
E. faecium
and 36
vanA
type) without cross-reaction (100% specificity). The lower detection limit of the RPA-LF was approximately 10 times better than that of the conventional PCR method. The RPA-LF method is an alternative rapid method with excellent sensitivity and specificity for detecting
E. faecium
,
vanA
, and
vanB
, and it has the potential to be used as a point-of-care device for VRE therapy and prevention.
Title: Rapid detection of
Enterococcus
and vancomycin resistance using recombinase polymerase amplification
Description:
Vancomycin-resistant enterococci (VRE), especially
Enterococcus faecium
, have been a global concern, often causing serious healthcare-associated infections.
We established a rapid approach for detecting
E.
faecium
and vancomycin-resistance genes (
vanA
and
vanB
) in clinical samples using isothermal recombinase polymerase amplification (RPA) combined with a lateral-flow (LF) strip.
Specific RPA primer sets and probes for
ddl
(to identify the presence of
E.
faecium
)
vanA
and
vanB
genes were designed.
The RPA reaction was performed under isothermal condition at 37 °C within 20 min and read using the LF strip within a further 5 min.
A total of 141 positive blood-cultures and 136 stool/rectal swab samples were tested using RPA-LF method compared to the conventional PCR method.
The RPA-LF method exhibited 100% sensitivity in both blood-culture (60
E.
faecium
; 35
vanA
type and two
vanB
type) and stool/rectal-swab samples (63
E.
faecium
and 36
vanA
type) without cross-reaction (100% specificity).
The lower detection limit of the RPA-LF was approximately 10 times better than that of the conventional PCR method.
The RPA-LF method is an alternative rapid method with excellent sensitivity and specificity for detecting
E.
faecium
,
vanA
, and
vanB
, and it has the potential to be used as a point-of-care device for VRE therapy and prevention.
Related Results
Controlling the Evolution of Selective Vancomycin Resistance through Successful Ophthalmic Eye-Drop Preparation of Vancomycin-Loaded Nanoliposomes Using the Active-Loading Method
Controlling the Evolution of Selective Vancomycin Resistance through Successful Ophthalmic Eye-Drop Preparation of Vancomycin-Loaded Nanoliposomes Using the Active-Loading Method
Vancomycin is the front-line defense and drug of choice for the most serious and life-threatening methicillin-resistant Staphylococcus aureus (MRSA) infections. However, poor vanco...
Can local application of vancomycin reduce surgical site infection rate after open lumbar fusion surgery?: A multicenter retrospective cohort study
Can local application of vancomycin reduce surgical site infection rate after open lumbar fusion surgery?: A multicenter retrospective cohort study
Surgical site infection (SSI) after posterior open lumbar fusion (POLF) is a major concern for both surgeons and patients. We sought to explore whether local application of vancomy...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide
In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide
LY333328 is a semisynthetic N-alkyl derivative of LY264826, a naturally occurring structural analog of vancomycin. LY333328 was evaluated for its in vitro inhibitory and bactericid...
Optimization of the electroporation procedure for OG1RF Enterococcus faecalis to study VanRS_B activation using VanRS_B-GFP reporter construct
Optimization of the electroporation procedure for OG1RF Enterococcus faecalis to study VanRS_B activation using VanRS_B-GFP reporter construct
Antibiotic-resistant infections have become an increasing threat in modern medicine, since wide-spread antibiotic use in modern medicine. Understanding the resistance mechanisms th...
Immune-Mediated Thrombocytopenia in Patients Treated with Vancomycin.
Immune-Mediated Thrombocytopenia in Patients Treated with Vancomycin.
Abstract
Numerous drugs are known to cause immune thrombocytopenia (TP) mediated by antibodies (abs) that bind to platelets only when the sensitizing drug is present...
Probable Vancomycin-Induced Neutropenia
Probable Vancomycin-Induced Neutropenia
OBJECTIVE To report a case of vancomycin-induced neutropenia and provide a review of the literature. CASE SUMMARY A 64-year-old white man was treated with intravenous vancomycin 1....
In Vitro Assessment of Vancomycin HCl Compatibility after Coinfusion with a Specialized Amino Acid Formulation
In Vitro Assessment of Vancomycin HCl Compatibility after Coinfusion with a Specialized Amino Acid Formulation
Vancomycin usage at British Columbia's Children's Hospital has increased substantially in the Special Care Nursery as a consequence of a study demonstrating a reduced morbidity and...

